Patents by Inventor Sachie Sogo

Sachie Sogo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9650380
    Abstract: A compound having an URAT1 inhibitory activity, and an URAT1 inhibitor, a blood uric acid level-reducing agent and a pharmaceutical composition containing the compound. More specifically, a compound represented by the formula (I): wherein R1 is -Q1-A1 or the like; R2 is a hydrogen atom, a halogen atom, a lower alkyl group or the like; W1, W2, W3 and W4 are each independently a nitrogen atom or a methine group optionally having substituents, or the like; X and Y are each a single bond, an oxygen atom or the like; Z is a hydroxyl group or COOR3 or the like.
    Type: Grant
    Filed: October 27, 2016
    Date of Patent: May 16, 2017
    Assignee: SATO PHARMACEUTICAL CO., LTD.
    Inventors: Keita Nagai, Motoaki Baba, Shinichi Fujioka, Koh Nagasawa, Hirobumi Takahashi, Eri Kondoh, Sachie Sogo, Kenichi Tanaka, Yoshiki Itoh
  • Publication number: 20170044158
    Abstract: A compound having an URAT1 inhibitory activity, and an URAT1 inhibitor, a blood uric acid level-reducing agent and a pharmaceutical composition containing the compound. More specifically, a compound represented by the formula (I): wherein R1 is -Q1-A1 or the like; R2 is a hydrogen atom, a halogen atom, a lower alkyl group or the like; W1, W2, W3 and W4 are each independently a nitrogen atom or a methine group optionally having substituents, or the like; X and Y are each a single bond, an oxygen atom or the like; Z is a hydroxyl group or COOR3 or the like.
    Type: Application
    Filed: October 27, 2016
    Publication date: February 16, 2017
    Applicant: SATO PHARMACEUTICAL CO., LTD.
    Inventors: Keita NAGAI, Motoaki BABA, Shinichi FUJIOKA, Koh NAGASAWA, Hirobumi TAKAHASHI, Eri KONDOH, Sachie SOGO, Kenichi TANAKA, Yoshiki ITOH
  • Patent number: 9512119
    Abstract: The present invention relates to a compound having an URAT1 inhibitory activity, and to an URAT1 inhibitor, a blood uric acid level-reducing agent and a pharmaceutical composition containing the compound. More specifically, the present invention relates to a compound represented by the formula (I): wherein R1 is -Q1-A1 or the like; R2 is a hydrogen atom, a halogen atom, a lower alkyl group or the like; W1, W2, W3 and W4 are each independently a nitrogen atom or a methine group optionally having substituents, or the like; X and Y are each a single bond, an oxygen atom or the like; Z is a hydroxyl group or COOR3 or the like.
    Type: Grant
    Filed: July 26, 2013
    Date of Patent: December 6, 2016
    Assignee: SATO PHARMACEUTICAL CO., LTD.
    Inventors: Keita Nagai, Motoaki Baba, Shinichi Fujioka, Koh Nagasawa, Hirobumi Takahashi, Eri Kondoh, Sachie Sogo, Kenichi Tanaka, Yoshiki Itoh
  • Publication number: 20150191463
    Abstract: The present invention relates to a compound having an URAT1 inhibitory activity, and to an URAT1 inhibitor, a blood uric acid level-reducing agent and a pharmaceutical composition containing the compound. More specifically, the present invention relates to a compound represented by the formula (I): wherein R1 is -Q1-A1 or the like; R2 is a hydrogen atom, a halogen atom, a lower alkyl group or the like; W1, W2, W3 and W4 are each independently a nitrogen atom or a methine group optionally having substituents, or the like; X and Y are each a single bond, an oxygen atom or the like; Z is a hydroxyl group or COOR3 or the like.
    Type: Application
    Filed: July 26, 2013
    Publication date: July 9, 2015
    Applicant: SATO PHARMACEUTICAL CO., LTD.
    Inventors: Keita Nagai, Motoaki Baba, Shinichi Fujioka, Koh Nagasawa, Hirobumi Takahashi, Eri Kondoh, Sachie Sogo, Kenichi Tanaka, Yoshiki Itoh